NanoFuse Biologics, Inspan and Sacrix merged into Nanisx to push minimally invasive spine technologies. A CEO for Nanisx is expected to be announced in the near future.
NanoFuse Biologics focuses on bone healing and fusion with a fiber-based bioactive glass combined with a demineralized bone matrix. The company merged to form Nanisx to help build its team and expand its market share in orthobiologics.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
